Next Article in Journal
Screening of Panamanian Plant Extracts for Pesticidal Properties and HPLC-Based Identification of Active Compounds
Previous Article in Journal
Validated Stability-Indicating RP-HPLC Method for the Estimation of Degradation Behaviour of Organic Peroxide and Third-Generation Synthetic Retinoids in Topical Pharmaceutical Dosage Formulation
Article Menu

Export Article

Open AccessArticle
Sci. Pharm. 2015, 83(2), 339-352; doi:10.3797/scipharm.1503-03

A Rapid, Cost-Effective Pre-Clinical Method to Screen for Pro- or Antiarrhythmic Effects of Substances in an Isolated Heart Preparation

1
8, No 40 Dingli Court, Howard Str, Sliema, SLM 1751, Malta.
2
Department of Pharmacology, Medical School, University of Bristol, BS81TD, United Kingdom.
Received: 1 March 2015 / Accepted: 13 April 2015 / Published: 13 April 2015
Download PDF [906 KB, uploaded 7 September 2016]

Abstract

This study describes a rapid, cost-effective pre-clinical method to screen for pro- or antiarrhythmic effects of substances in an isolated heart preparation in line with the regulatory requirements of ICHS7B. The computational method “MFC method” quantifies arrhythmic episodes from isolated perfused hearts based on measuring the variation in the maximum force of contraction. Experiments were performed on hearts isolated from male Wistar rats. Arrhythmias were induced by the addition of tefluthrin or by ligation of the left coronary artery. The “MFC method” accurately measures the maximum force of every myocardial contraction and correlates it with the magnitude of the preceding beat. Arrhythmias were quantified by determining the coefficient of variation in the maximum force of contraction. This method is a useful approach to quickly identify the pro- or antiarrhythmic effects of drugs prior to more detailed analysis; particularly where the effects are varied and not easily classified under the Lambeth Conventions. Therefore, the “MFC method” can be used as a rapid screen for the antiarrhythmic effects of novel compounds or for rapidly determining potential cardiac toxicity.
Keywords: Arrhythmia; Contractile variation; Coronary ligation; Lambeth Conventions; ICHS7B Arrhythmia; Contractile variation; Coronary ligation; Lambeth Conventions; ICHS7B
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

BORG, J.J. A Rapid, Cost-Effective Pre-Clinical Method to Screen for Pro- or Antiarrhythmic Effects of Substances in an Isolated Heart Preparation. Sci. Pharm. 2015, 83, 339-352.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top